Endogenous Mineralization, Inclusions, and Deposition Disorders

  • Carol F. Farver
  • David H. Dail


The entities discussed in this chapter are diverse. Many come under the heading of metabolic diseases, which may be congenital or acquired. Others have, or act through, an immunologic basis. A few have a single identifiable cause. Some represent a common tissue response to multiple identified causes, while others appear to have no known causes.


Arch Pathol Plasma Cell Granuloma Pulmonary Alveolar Proteinosis Sclerosing Hemangioma Metastatic Calcification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wilks S. Ossific deposits on larynx, trachea and bronchi. Trans Pathol Soc (Lond) 1857;8:88.Google Scholar
  2. 2.
    Nienhuis DM, Prakash UB, Edell ES. Tracheobroncho-pathia osteochondroplastica. Ann Otol Rhinol Laryngol 1990;99:689–694.PubMedGoogle Scholar
  3. 3.
    Aschoff-Freiburg L. Über Tracheopathia osteoplastica. Verh Dtsch Pathol Ges 1910;14:125–127.Google Scholar
  4. 4.
    Prakash UB, McCullough AE, Edell ES, et al. Tracheopathia osteoplastica: familial occurrence. Mayo Clin Proc 1989;64(9):1091–1096.PubMedGoogle Scholar
  5. 5.
    Prakash UB. Tracheobronchopathia Osteochondroplastica. Semin Respir Crit Care Med 2002;23:67–75.Google Scholar
  6. 6.
    Dalgaard JB. Tracheopathia chondro-osteoplastica: a case elucidating the problems concerning development and ossification of elastic cartilage. Acta Pathol Microbiol Scand 1947;24:18–34.Google Scholar
  7. 7.
    Martin CJ. Tracheobronchopathia osteochondroplastica. Arch Otolaryngol 1974;100(4):290–293.PubMedGoogle Scholar
  8. 8.
    Eimind K. Tracheopathia chondro-osteoplastica. Nord Med 1964;72:1029–1031.PubMedGoogle Scholar
  9. 9.
    Jepsen O, Sorensen H. Tracheopathia osteoplastica and ozaena. Acta Otolaryngol 1960;51:79–83.PubMedGoogle Scholar
  10. 10.
    Sen RP, Walsh TE. Fiberoptic bronchoscopy for refractory cough. Chest 1991;99:33–35.PubMedGoogle Scholar
  11. 11.
    Restrepo S, Pandit M, Villamil MA, et al. Tracheobronchopathia osteochondroplastica: helical CT findings in 4 cases. J Thorac Imaging 2004;19:112–116.PubMedGoogle Scholar
  12. 12.
    Carr DT, Olsen AM. Tracheopathia osteoplastica. JAMA 1954;155:1563–1565.Google Scholar
  13. 13.
    Härmä RA, Suurkari S. Tracheopathia chondro-osteoplastica. A clinical study of thirty cases. Acta Otolaryngol 1977;84:118–123.PubMedGoogle Scholar
  14. 14.
    Hodges MK, Israel E. Tracheobronchopathia osteochondroplastica presenting as right middle lobe collapse. Diagnosis by bronchoscopy and computerized tomography. Chest 1988;94:842–844.PubMedGoogle Scholar
  15. 15.
    Pounder DJ, Pieterse AS. Tracheopathia osteoplastica: a study of the minimal lesion. J Pathol 1982;138:235–239.PubMedGoogle Scholar
  16. 16.
    Tajima K, Yamakawa M, Katagiri T, et al. Immunohistochemical detection of bone morphogenetic protein-2 and transforming growth factor beta-1 in tracheopathia osteochondroplastica. Virchows Arch 1997;431:359–363.PubMedGoogle Scholar
  17. 17.
    Alroy GG, Lichtig C, Kaftori JK. Tracheobronchopathia osteoplastica: end stage of primary lung amyloidosis? Chest 1972;61:465–468.PubMedGoogle Scholar
  18. 18.
    Sakula A. Tracheobronchopathia osteoplastica: its relationship to primary tracheobronchial amyloidosis. Thorax 1968;23:105–110.PubMedGoogle Scholar
  19. 19.
    Shuttleworth JS, Self CL, Pershing HS. Tracheopathia osteoplastica. Ann Intern Med 1960;52:234–242.PubMedGoogle Scholar
  20. 20.
    Hui AN, Koss MN, Hochholzer L, et al. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med 1986;110:212–218.PubMedGoogle Scholar
  21. 21.
    Baugnee PE, Delaunois LM. Mycobacterium avium-intracellulare associated with tracheobronchopathia osteochondroplastica. Eur Respir J 1995;8:180–182.PubMedGoogle Scholar
  22. 22.
    Kocyildirim E, Kanani M, Roebuck D, et al. Long-segment tracheal stenosis: slide tracheoplasty and a multidisciplinary approach improve outcomes and reduce costs. J Thorac Cardiovasc Surg 2004;128:876–882.PubMedGoogle Scholar
  23. 23.
    Shin JH, Song HY, Shim TS. Management of tracheobronchial strictures. Cardiovasc Intervent Radiol 2004;27:314–324.PubMedGoogle Scholar
  24. 24.
    Urbach E, Wiethe C. Lipoidosis cutis et mucosae. Arch Pathol Anat 1929;273:285–219.Google Scholar
  25. 25.
    Caplan RM. Visceral involvement in lipoid proteinosis. Arch Dermatol 1967;95:149–155.PubMedGoogle Scholar
  26. 26.
    Acar A, Eryilmaz A, Gocer C, et al. Lipoid proteinosis of larynx: review of four cases. Int J Pediatr Otorhinolaryngol 2004;68:1557–1561.PubMedGoogle Scholar
  27. 27.
    Moscovic EA. Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathol Annu 1978;13:69–164.PubMedGoogle Scholar
  28. 28.
    Carstens PH, Kuhns JG, Ghazi C. Primary malignant melanomas of the lung and adrenal. Hum Pathol 1984;15:910–914.PubMedGoogle Scholar
  29. 29.
    Salm R. A primary malignant melanoma of the bronchus. J Pathol Bacteriol 1963;85:121–126.PubMedGoogle Scholar
  30. 30.
    Allen MS Jr, Drash EC. Primary melanoma of the lung. Cancer 1968;21:154–159.PubMedGoogle Scholar
  31. 31.
    Rocken C, Sletten K. Amyloid in surgical pathology. Virch Arch 2003;443:3–16Google Scholar
  32. 32.
    Hirschfield GM. Amyloidosis: a clinico-pathophysiological synopsis. Semin Cell Dev Biol 2004;15:39–44.PubMedGoogle Scholar
  33. 33.
    Chen KT. Amyloidosis presenting in the respiratory tract. Pathol Annu 1989;24:253–273.PubMedGoogle Scholar
  34. 34.
    Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 2000;45:107–137.PubMedGoogle Scholar
  35. 35.
    Gertz MA, Kyle RA. Primary systemic amyloidosis—a diagnostic primer. Mayo Clin Proc 1989;64:1505–1519.PubMedGoogle Scholar
  36. 36.
    Kaplan B, Martin BM, Livneh A, et al. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol 2004;121:794–800.PubMedGoogle Scholar
  37. 37.
    Rocken C, Sletten K. Amyloid in surgical pathology. Virchows Arch 2003;443:3–16.PubMedGoogle Scholar
  38. 38.
    Glenner GG. Amyloid deposits and amyloidosis. The betafibrilloses (first of two parts). N Engl J Med 1980;302:1283–1292.PubMedGoogle Scholar
  39. 39.
    Page DL, Isersky C, Harada M, et al. Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berlin) 1972;159:75–86.Google Scholar
  40. 40.
    Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest 1977;36:274–281.PubMedGoogle Scholar
  41. 41.
    van Rijswijk MH, van Heusden CW. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice. Am J Pathol 1979;97:43–58.PubMedGoogle Scholar
  42. 42.
    Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest 1986;90:827–831.PubMedGoogle Scholar
  43. 43.
    Gertz MA, Greipp PR. Clinical aspects of pulmonary amyloidosis. Chest 1986;90:790–791.PubMedGoogle Scholar
  44. 44.
    Cohen AS. Amyloidosis (concluded). N Engl J Med 1967;277:628–638.PubMedGoogle Scholar
  45. 45.
    Klatskin G. Nonspecific green birefringence in Congo red-stained tissues. Am J Pathol 1969;56:1–13.PubMedGoogle Scholar
  46. 46.
    Toriumi J. The lung in generalized amyloidosis. Acta Pathol Jpn 1972;22:141–152.PubMedGoogle Scholar
  47. 47.
    Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore) 1975;54:271–299.PubMedGoogle Scholar
  48. 48.
    Serpell LC, Sunde M, Blake CC. The molecular basis of amyloidosis. Cell Mol Life Sci 1997;53:871–887.PubMedGoogle Scholar
  49. 49.
    Linke RP. Highly sensitive diagnosis of amyloid and various amyloid syndromes using congo red fluorescence. Virch Arch 2000;436:439–448.Google Scholar
  50. 50.
    Reiman HA, Koucky RF, Ecklung CM. Primary amyloidosis limited to tissue of mesodermal origin. Am J Pathol 1935;11:977–988.Google Scholar
  51. 51.
    Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med 1974;290:473–477.PubMedGoogle Scholar
  52. 52.
    Duff GL. Primary systemic sarcoidosis: a diagnostic primer. Am J Med Sci 1954;328:317–333.Google Scholar
  53. 53.
    Dahlin DC. Primary amyloidosis, with report of six cases. Am J Pathol 1949;25:105–123.PubMedGoogle Scholar
  54. 54.
    Smith RR, Hutchins GM, Moore GW, et al. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med 1979;66:96–104.PubMedGoogle Scholar
  55. 55.
    Celli BR, Rubinow A, Cohen AS, et al. Patterns of pulmonary involvement in systemic amyloidosis. Chest 1978;74:543–547.PubMedGoogle Scholar
  56. 56.
    Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med 1996;124:407–413.PubMedGoogle Scholar
  57. 57.
    Kuhlback B, Wegelius O. Secondary amyloidosis: a study of clinical and pathological findings. Acta Med Scand 1966;180:737–745.PubMedGoogle Scholar
  58. 58.
    McGlennen RC, Burke BA, Dehner LP. Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study. Arch Pathol Lab Med 1986;110:879–884.PubMedGoogle Scholar
  59. 59.
    Munoz-Bonet JI, Ibarra I, Perez-Navero JL, et al. Secondary amyloidosis detected in a patient with cystic fibrosis after undergoing lung transplantation. Transplantation 2002;73:1173–1174.PubMedGoogle Scholar
  60. 60.
    Stokes MB, Jagirdar J, Burchstin O, et al. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod Pathol 1997;10:1059–1065.PubMedGoogle Scholar
  61. 61.
    Shah SP, Khine M, Anigbogu J, et al. Nodular amyloidosis of the lung from intravenous drug abuse: an uncommon cause of multiple pulmonary nodules. South Med J 1998;91:402–404.PubMedGoogle Scholar
  62. 62.
    Jayalakshmi P, Looi LM, Lim KJ, et al. Autopsy findings in 35 cases of leprosy in Malaysia. Int J Lepr Other Mycobact Dis 1987;55:510–514.PubMedGoogle Scholar
  63. 63.
    Pitkanen P, Westermark P, Cornwell GG, III. Senile systemic amyloidosis. Am J Pathol 1984;117:391–399.PubMedGoogle Scholar
  64. 64.
    Laden SA, Cohen ML, Harley RA. Nodular pulmonary amyloidosis with extrapulmonary involvement. Hum Pathol 1984;15:594–597.PubMedGoogle Scholar
  65. 65.
    Monreal FA. Pulmonary amyloidosis: ultrastructural study of early alveolar septal deposits. Hum Pathol 1984;15:388–390.PubMedGoogle Scholar
  66. 66.
    Rubinow A, Celli BR, Cohen AS, et al. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis 1978;118:603–611.PubMedGoogle Scholar
  67. 67.
    Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax 1999;54:444–451.PubMedGoogle Scholar
  68. 68.
    Thompson PJ, Citron KM. Amyloid and the lower respiratory tract. Thorax 1983;38:84–87.PubMedGoogle Scholar
  69. 69.
    Thompson PJ, Jewkes J, Corrin B, et al. Primary bronchopulmonary amyloid tumour with massive hilar lymphade-nopathy. Thorax 1983;38:153–154.PubMedGoogle Scholar
  70. 70.
    Lesser A. Ein Fall von Enchondroma osteiodes mixtum der Lunge mit partieller Amyloidentartung. Virchows Arch Pathol Anat 1877;69:404–408.Google Scholar
  71. 71.
    Prowse CB. Amyloidosis of the lower respiratory tract. Thorax 1958;13:308–320.PubMedGoogle Scholar
  72. 72.
    Balser W. Tracheo und Bronchialstenose mit Amyloid in der Wandungen der Leftwege. Virchows Arch Pathol Anat 1883;91:67–76.Google Scholar
  73. 73.
    Dood AR, Mann JD. Primary diffuse amyloidosis of the respiratory tract. AMA Arch Pathol 1959;67:39–42.PubMedGoogle Scholar
  74. 74.
    Gottlieb LS, Gold WM. Primary tracheobronchial amyloidosis. Am Rev Respir Dis 1972;105:425–429.PubMedGoogle Scholar
  75. 75.
    O’Regan A, Fenlon HM, Beamis JF Jr, et al. Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999. Medicine (Baltimore) 2000;79:69–79.PubMedGoogle Scholar
  76. 76.
    Strange C, Heffner JE, Collins BS, et al. Pulmonary hemorrhage and air embolism complicating transbronchial biopsy in pulmonary amyloidosis. Chest 1987;92:367–369.PubMedGoogle Scholar
  77. 77.
    Road JD, Jacques J, Sparling JR. Diffuse alveolar septal amyloidosis presenting with recurrent hemoptysis and medial dissection of pulmonary arteries. Am Rev Respir Dis 1985;132:1368–1370.PubMedGoogle Scholar
  78. 78.
    Revol L, Mournier-Kuhn P, Paliard Petal. L’amyloidose primitive de l’abre tracheobronchique à propos d’un nouveau cas. Rev Med Lyon 1965;14:583–585.Google Scholar
  79. 79.
    Jones AW, Chatterji AN. Primary tracheobronchial amyloidosis with tracheobronchopathia osteoplastica. Br J Dis Chest 1977;71:268–272.PubMedGoogle Scholar
  80. 80.
    Rejou JJ, Bannier M. Amylose bronchique primitive et tracheopathie chondreosteoplastique. Quest Med 1978;31:197–201.Google Scholar
  81. 81.
    Loire R, Saugier J, Brune J, et al. Amylose et tracheobronchopathie osteoplastique a propose de trois observations. Lyon Med 1978;239:75–78.Google Scholar
  82. 82.
    Lee SC, Johnson H. Multiple nodular pulmonary amyloidosis. A case report and comparison with diffuse alveolar-septal pulmonary amyloidosis. Thorax 1975;30:178–185.PubMedGoogle Scholar
  83. 83.
    Desai RA, Mahajan VK, Benjamin S, et al. Pulmonary amyloidoma and hilar adenopathy. Rare manifestations of primary amyloidosis. Chest 1979;76:170–173.PubMedGoogle Scholar
  84. 84.
    Firestone FN, Joison J. Amyloidosis. A cause of primary tumors of the lung. J Thorac Cardiovasc Surg 1966;51:292–299.PubMedGoogle Scholar
  85. 85.
    Saab SB, Burke J, Hopeman A, et al. Primary pulmonary amyloidosis. Report of two cases. J Thorac Cardiovasc Surg 1974;67:301–307.PubMedGoogle Scholar
  86. 86.
    Becker BJP. Tumour-forming amyloidosis of the lung. Med Proc 1961;7:107–109.Google Scholar
  87. 87.
    Fenoglio C, Pascal RR. Nodular amyloidosis of the lungs. An unusual case associated with chronic lung disease and carcinoma of the bladder. Arch Pathol 1970;90:577–582.PubMedGoogle Scholar
  88. 88.
    Ikeda S, Takabayashi Y, Maejima Y, et al. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis. Amyloid 1999;6:292–296.PubMedGoogle Scholar
  89. 89.
    Battaglia S, Masini T. Paramilodosi neoplastiforme del polmone. Folia Hered Pathol 1957;6:69–127.Google Scholar
  90. 90.
    Weiss L. Isolated multiple nodular pulmonary amyloidosis. Am J Clin Pathol 1960;33:318–329.PubMedGoogle Scholar
  91. 91.
    Himmelfarb E, Wells S, Rabinowitz JG. The radiologic spectrum of cardiopulmonary amyloidosis. Chest 1977;72:327–332.PubMedGoogle Scholar
  92. 92.
    Eisenberg R, Sharma OP. Primary pulmonary amyloidosis. An unusual case with 14 years’ survival. Chest 1986;89:889–891.PubMedGoogle Scholar
  93. 93.
    Kobayashi H, Matsuoka R, Kitamura S, et al. Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 1988;94:438–440.PubMedGoogle Scholar
  94. 94.
    Bonner H Jr, Ennis RS, Geelhoed GW, et al. Lymphoid infiltration and amyloidosis of lung in Sjogren’s syndrome. Arch Pathol 1973;95:42–44.PubMedGoogle Scholar
  95. 95.
    Davis CJ, Butchart EG, Gibbs AR. Nodular pulmonary amyloidosis occurring in association with pulmonary lymphoma. Thorax 1991;46:217–218.PubMedGoogle Scholar
  96. 96.
    Dacic S, Colby TV, Yousem SA. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem. Mod Pathol 2000;13:934–940.PubMedGoogle Scholar
  97. 97.
    Lim JK, Lacy MQ, Kurtin PJ, et al. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol 2001;54:642–646.PubMedGoogle Scholar
  98. 98.
    Brown J. Primary Amyloidosis. Clin Radiol 1964;15:358–367.PubMedGoogle Scholar
  99. 99.
    Dirkse PR. Primary amyloidosis of the lungs. Am J Roentgenol Radium Ther Nucl Med 1946;56:577–585.Google Scholar
  100. 100.
    Garcia GF, Calleja Canelas JL. Letter: hilar enlargement in amyloidosis. N Engl J Med 1974;291:531.Google Scholar
  101. 101.
    Ito M, Sugiyama E, Akagawa N, et al. Immunological studies on an unusual case of primary pulmonary amyloidosis with hilar adenopathy. Jpn J Med 1982;21:216–222.PubMedGoogle Scholar
  102. 102.
    Kidd CR, Fred HL, Natelson EA. Letter: Bilateral hilar adenopathy in amyloidosis. N Engl J Med 1974;290:972.PubMedGoogle Scholar
  103. 103.
    Shaw P, Grossman R, Fernandes BJ. Nodular mediastinal amyloidosis. Hum Pathol 1984;15:1183–1185.PubMedGoogle Scholar
  104. 104.
    Melato M, Antonutto G, Falconieri G, et al. Massive amyloidosis of mediastinal lymph nodes in a patient with multiple myeloma. Thorax 1983;38:151–152.PubMedGoogle Scholar
  105. 105.
    Hsiu JG, Stitik FP, D’Amato NA, et al. Primary amyloidosis presenting as a unilateral hilar mass. Report of a case diagnosed by fine needle aspiration biopsy. Acta Cytol 1986;30:55–58.PubMedGoogle Scholar
  106. 106.
    Kanada DJ, Sharma OP. Long-term survival with diffuse interstitial pulmonary amyloidosis. Am J Med 1979;67:879–882.PubMedGoogle Scholar
  107. 107.
    Shiue ST, McNally DP. Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis. Arch Intern Med 1988;148:687–689.PubMedGoogle Scholar
  108. 108.
    Dingli D, Utz JP, Gertz MA. Pulmonary hypertension in patients with amyloidosis. Chest 2001;120:1735–1738.PubMedGoogle Scholar
  109. 109.
    Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises; case 48-1977. N Engl J Med 1977;297:1221–1228.Google Scholar
  110. 110.
    Lundin P, Simonsson B, Winberg T. Pneumonopleural amyloid tumour. Report of a case. Acta Radiol 1961;55:139–144.PubMedGoogle Scholar
  111. 111.
    Vilaseca J, Cuevas J, Fresno M, et al. Systemic amyloidosis in cystic fibrosis. Am J Dis Child 1981;135:667.PubMedGoogle Scholar
  112. 112.
    Graham DR, Ahmad D. Clinical aspects of pulmonary amyloidosis. Chest 1987;92:576–577.PubMedGoogle Scholar
  113. 113.
    Knapp MJ, Roggli VL, Kim J, et al. Pleural amyloidosis. Arch Pathol Lab Med 1988;112:57–60.PubMedGoogle Scholar
  114. 114.
    Kavuru MS, Adamo JP, Ahmad M, et al. Amyloidosis and pleural disease. Chest 1990;98:20–23.PubMedGoogle Scholar
  115. 115.
    Gonzalez-Cueto DM, Rigoli M, Gioseffi LM, et al. Diffuse pulmonary amyloidosis. Am J Med 1970;48:668–670.PubMedGoogle Scholar
  116. 116.
    Poh SC, Tjia TS, Seah HC. Primary diffuse alveolar septal amyloidosis. Thorax 1975;30:186–191.PubMedGoogle Scholar
  117. 117.
    Rajan VT, Kikkawa Y Alveolar septal amyloidosis in primary amyloidosis. An electron microscopic study. Arch Pathol 1970;89:521–525.PubMedGoogle Scholar
  118. 118.
    Ohdama S, Akagawa S, Matsubara O, et al. Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification. Eur Respir J 1996;9:1569–1571.PubMedGoogle Scholar
  119. 119.
    Kijner CH, Yousem SA. Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature. Am J Surg Pathol 1988;12:405–413.PubMedGoogle Scholar
  120. 120.
    Seymour AE, Thompson AJ, Smith PS, et al. Kappa light chain glomerulosclerosis in multiple myeloma. Am J Pathol 1980;101:557–580.PubMedGoogle Scholar
  121. 121.
    Cohen JJ, Colvin RB. Case records of the Massachusetts General Hospital. N Engl J Med 1981;304:33–43.Google Scholar
  122. [22.
    Silver MM, Hearn SA, Ritchie S, et al. Renal and systemic kappa light chain deposits and their plasma cell origin identified by immunoelectron microscopy. Am J Pathol 1986;122:17–27.PubMedGoogle Scholar
  123. 123.
    Warfel KA, Benson MD, Hull MD, et al. Pulmonary nodules and pleural plaques in systemic light chain deposition disease. Lab Invest 1987;56:84 (abstr).Google Scholar
  124. 124.
    Hoffman-Guilaine C, Nochy D, Tricottet V, et al. La maladie des dépots de chaines légéres: une entité anatomo-pathologique. Annu Pathol 1984;4:105–113.Google Scholar
  125. 125.
    Jacquot C, Saint-Andre JP, Touchard G, et al. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement. Clin Nephrol 1985;24:93–98.PubMedGoogle Scholar
  126. 126.
    Linder J, Croker BP, Vollmer RT, et al. Systemic kappa light-chain deposition. An ultrastructural and immunohis-tochemical study. Am J Surg Pathol 1983;7:85–93.PubMedGoogle Scholar
  127. 127.
    Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light-and heavy-chain deposition diseases. Hematol Oncol Clin North Am 1999;13:1235–1248.PubMedGoogle Scholar
  128. 128.
    Khoor A, Myers JL, Tazelaar HD, et al. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases. Am J Clin Pathol 2004;121:200–204.PubMedGoogle Scholar
  129. 128.
    Engleman P, Liebow AA, Gmelich J, et al. Pulmonary hyalinizing granuloma. Am Rev Respir Dis 1977;115:997–1008.PubMedGoogle Scholar
  130. 130.
    Drasin H, Blume MR, Rosenbaum EH, et al. Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis. Cancer 1979;44:215–220.PubMedGoogle Scholar
  131. 131.
    Guccion JG, Rohatgi PK, Saini N. Pulmonary hyalinizing granuloma. Electron microscopic and immunologic studies. Chest 1984;85:571–573.PubMedGoogle Scholar
  132. 132.
    Schlosnagle DC, Check IJ, Sewell CW, et al. Immunologic abnormalities in two patients with pulmonary hyalinizing granuloma. Am J Clin Pathol 1982;78:231–235.PubMedGoogle Scholar
  133. 133.
    Chalaoui J, Gregoire P, Sylvestre J, et al. Pulmonary hyalinizing granuloma: a cause of pulmonary nodules. Radiology 1984;152:23–26.PubMedGoogle Scholar
  134. 134.
    Dent RG, Godden DJ, Stovin PG, et al. Pulmonary hyali-nising granuloma in association with retroperitoneal fibrosis. Thorax 1983;38:955–956.PubMedGoogle Scholar
  135. 135.
    Macedo EV, Adolph J. Pulmonary hyalinizing granulomas. J Can Assoc Radiol 1985;36:66–67.PubMedGoogle Scholar
  136. 136.
    Maijub AG, Giltman LI, Verner JL, et al. Pulmonary hyalinizing granuloma. Ann Allergy 1985;54:227–229.PubMedGoogle Scholar
  137. 137.
    Ikard RW. Pulmonary hyalinizing granuloma. Chest 1988;93:871–872.PubMedGoogle Scholar
  138. 138.
    Gans SJ, van der Elst AM, Straks W. Pulmonary hyalinizing granuloma. Eur Respir J 1988;1:389–391.PubMedGoogle Scholar
  139. 139.
    Patel Y, Ishikawa S, MacDonnell KF. Pulmonary hyalinizing granuloma presenting as multiple cavitary calcified nodules. Chest 1991;100:1720–1721.PubMedGoogle Scholar
  140. 140.
    Kuramochi S, Kawai T, Yakumaru K, et al. Multiple pulmonary hyalinizing granulomas associated with systemic idiopathic fibrosis. Acta Pathol Jpn 1991;41:375–382.PubMedGoogle Scholar
  141. 141.
    Anazawa Y, Nagai H, Motomiya M, et al. A case of pulmonary hyalinizing granuloma. Tohoku J Exp Med 1992;167:39–45.PubMedGoogle Scholar
  142. 142.
    Atagi S, Sakatani M, Akira M, et al. Pulmonary hyalinizing granuloma with Castleman’s disease. Intern Med 1994;33:689–691.PubMedGoogle Scholar
  143. 143.
    Pinckard JK, Rosenbluth DB, Patel K, et al. Pulmonary hyalinizing granuloma associated with Aspergillus infection. Int J Surg Pathol 2003;11:39–42.PubMedGoogle Scholar
  144. 144.
    Shinohara T, Kaneko T, Miyazawa N, et al. Pulmonary hyalinizing granuloma with laryngeal and subcutaneous involvement: report of a case successfully treated with glucocorticoids. Intern Med 2004;43:69–73.PubMedGoogle Scholar
  145. 145.
    Yousem SA, Hochholzer L. Pulmonary hyalinizing granuloma. Am J Clin Pathol 1987;87:1–6.PubMedGoogle Scholar
  146. 146.
    Schmidt RMD. Personal communication, University School of Medicine, Seattle, Washington, 1991.Google Scholar
  147. 147.
    Ren Y, Raitz EN, Lee KR, et al. Pulmonary small lymphocytic lymphoma (mucosa-associated lymphoid tissue type) associated with pulmonary hyalinizing granuloma. Chest 2001;120:1027–1030.PubMedGoogle Scholar
  148. 148.
    Katzenstein AL, Mazur MT. Pulmonary infarct: an unusual manifestation of fibrosing mediastinitis. Chest 1980;77:521–524.PubMedGoogle Scholar
  149. 149.
    Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972;51:227–246.PubMedGoogle Scholar
  150. 150.
    Schowengerdt CG, Suyemoto R, Main FB. Granulomatous and fibrous mediastinitis. A review and analysis of 180 cases. J Thorac Cardiovasc Surg 1969;57:365–379.PubMedGoogle Scholar
  151. 151.
    Ulbright TM, Katzenstein AL. Solitary necrotizing granulomas of the lung: differentiating feature and etiology. Am J Surg Pathol 1980;4:13–28.PubMedGoogle Scholar
  152. 152.
    Gorini M, Forloni F, Pezzoli A, et al. Pulmonary hyalinizing granuloma. A limited form of Wegener’s granulomatosis? Ann Ital Med Int 1998;13:176–179.PubMedGoogle Scholar
  153. 153.
    Soergel KH, Sommers SC. The alveolar epithelial lesion of idiopathic pulmonary hemosiderosis. Am Rev Respir Dis 1962;85:540–552.Google Scholar
  154. 154.
    Dail DH, Leibow AA, Gmelich J, et al. A study of 43 cases of pulmonary veno-occlusive (PVO) disease. (Abstract). Lab Invest 1978;340–341.Google Scholar
  155. 155.
    Pai U, McMahon J, Tomashefski JF, Jr. Mineralizing pulmonary elastosis in chronic cardiac failure. “Endogenous pneumoconiosis” revisited. Am J Clin Pathol 1994;101:22–28.PubMedGoogle Scholar
  156. 156.
    Walton KW, Heath D. Iron incrustation of the pulmonary vessels in patent ductus arteriosus with congenital mitral disease. Br Heart J 1960;22:440–44.PubMedGoogle Scholar
  157. 157.
    Heath D, Smith P. Plexiform lesions with giant cells. Thorax 1982;37:394–395.PubMedGoogle Scholar
  158. 158.
    Kaplan L, Walford RL. Pulmonary fibrosis and giant-cell reaction with altered elastic tissue; endogenous pneumoconiosis. AMA Arch Pathol 1957;63:75–90.PubMedGoogle Scholar
  159. 159.
    Chan ED, Morales DV, Welsh CH, et al. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 2002;165:1654–1669.PubMedGoogle Scholar
  160. 160.
    Virchow R. Kalk-metastasen. Virchows Arch Pathol Anat 1855;8:103–113.Google Scholar
  161. 161.
    Mulligan RM. Metastatic calcification. Arch Pathol 1947;43:177–230.Google Scholar
  162. 162.
    Neff M, Yalcin S, Gupta S, et al. Extensive metastatic calcification of the lung in an azotemic patient. Am J Med 1974;56:103–109.PubMedGoogle Scholar
  163. 163.
    Kuzela DC, Huffer WE, Conger JD, et al. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977;86:403–424.PubMedGoogle Scholar
  164. 164.
    Kaltreider HB, Baum GL, Bogaty G, et al. So-called “metastatic” calcification of the lung. Am J Med 1969;46:188–196.PubMedGoogle Scholar
  165. 165.
    Conger JD, Hammond WS, Alfrey AC, et al. Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med 1975;83:330–336.PubMedGoogle Scholar
  166. 166.
    Sanders C, Frank MS, Rostand SG, et al. Metastatic calcification of the heart and lungs in end-stage renal disease: detection and quantification by dual-energy digital chest radiography. AJR 1987;149:881–887.PubMedGoogle Scholar
  167. 167.
    Wang NS, Steele AA. Pulmonary calcification: scanning electron microscopic and X-ray energy-dispersive analysis. Arch Pathol Lab Med 1979;103:252–257.PubMedGoogle Scholar
  168. 168.
    Smith JC, Stanton LW, Kramer NC, et al. Nodular pulmonary calcification in renal failure. Report of a case. Am Rev Respir Dis 1969;100:723–728.PubMedGoogle Scholar
  169. 169.
    McLachlan MS, Wallace M, Seneviratne C. Pulmonary calcification in renal failure. Report of three cases. Br J Radiol 1968;41:99–106.PubMedGoogle Scholar
  170. 170.
    Bonin M, Miyai K. Metastatic pulmonary calcification, morphology, chemical and x-ray microanalysis. Lab Invest 1977;36:331.Google Scholar
  171. 171.
    van der Bij W, Gouw AS, Meinesz AF, et al. Consolidation of both upper lobes. Chest 1991;100:1685–1686.PubMedGoogle Scholar
  172. 172.
    Mootz JR, Sagel SS, Roberts TH. Roentgenographic manifestations of pulmonary calcifications. A rare cause of respiratory failure in chronic renal disease. Radiology 1973;107:55–60.PubMedGoogle Scholar
  173. 173.
    Kuhlman JE, Ren H, Hutchins GM, et al. Fulminant pulmonary calcification complicating renal transplantation: CT demonstration. Radiology 1989;173:459–460.PubMedGoogle Scholar
  174. 174.
    Bloodworth J, Tomashefski JF Jr. Localised pulmonary metastatic calcification associated with pulmonary artery obstruction. Thorax 1992;47:174–178.PubMedGoogle Scholar
  175. 175.
    Davidson JM, Macleod WM. Pulmonary alveolar proteinosis. Br J Dis Chest 1969;63:13–28.PubMedGoogle Scholar
  176. 176.
    Firooznia H, Pudlowski R, Golimbu C, et al. Diffuse interstitial calcification of the lungs in chronic renal failure mimicking pulmonary edema. AJR 1977;129:1103–1105.PubMedGoogle Scholar
  177. 177.
    Koshy MC, Weinstein E, Pope RH, et al. Letter: Calcific cardiomyopathy. N Engl J Med 1975;292:209–210.PubMedGoogle Scholar
  178. 178.
    Boner G, Jacob ET, Pevzner S, et al. Diffuse calcification of lungs in a patient on maintenance hemodialysis. Isr J Med Sci 1971;7:1182–1187.PubMedGoogle Scholar
  179. 179.
    Braude S, Graham A, Mitchell D. Lymphoedema/hypercal-caemia syndrome mediated by parathyroid-hormone-related protein. Lancet 1991;337:140–141.PubMedGoogle Scholar
  180. 180.
    Felson B. Chest roentgenography. Philadelphia: WB Saunders, 1973:479.Google Scholar
  181. 181.
    Wells HG. Calcification and ossification. Arch Intern Med 1911;7:721–753.Google Scholar
  182. 182.
    Hueper W. Metastatic calcification in the organs of the dog after injection of parathyroid extract. Arch Pathol Lab Med 1927;3:14–25.Google Scholar
  183. 183.
    Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697–701.PubMedGoogle Scholar
  184. 184.
    Heath D, Robertson AJ. Pulmonary calcinosis. Thorax 1977;32:606–611.PubMedGoogle Scholar
  185. 185.
    Bestetti-Bosisio M, Cotelli F, Schiaffino E, et al. Lung calcification in long-term dialysed patients: a light and electronmicroscopic study. Histopathology 1984;8:69–79.PubMedGoogle Scholar
  186. 186.
    Daust W. Über verästelte Knochenspangenbidung in der Lung. Frankfurt Z Pathol 1929;37:313–327.Google Scholar
  187. 187.
    Salinger H. Die Knochenbildungen in der Lunge mit besonderer Berücksichtigung der tuberösen Form. Fortschr Geb Röntgenstr 1932;46:269–275.Google Scholar
  188. 188.
    Janker R. Dei verästelten Knockenbildungen in der Lunge. Fortschr Röntgenstr 1936;53:840–860.Google Scholar
  189. 189.
    Wells HG, Dunlap CE. Disseminated ossification of the lungs. Arch Pathol Lab Med 1943;35:420–426.Google Scholar
  190. 190.
    Joines RW, Roggli VL. Dendriform pulmonary ossification. Report of two cases with unique findings. Am J Clin Pathol 1989;91:398–402.PubMedGoogle Scholar
  191. 191.
    Mtiller KM, Friemann J, Stichnoth E. Dendriform pulmonary ossification. Pathol Res Pract 1980;168:163–172.Google Scholar
  192. 192.
    Kuplic JB, Higley CS, Niewoehner DE. Pulmonary ossification associated with long-term busulfan therapy in chronic myeloid leukemia. Case report. Am Rev Respir Dis 1972;106:759–762.PubMedGoogle Scholar
  193. 193.
    Ndimbie OK, Williams CR, Lee MW. Dendriform pulmonary ossification. Arch Pathol Lab Med 1987;111:1062–1064.PubMedGoogle Scholar
  194. 194.
    Wilson WR, Sasaki R, Johnson CA. Disseminated nodular pulmonary ossification in patients with mitral stenosis. Circulation 1959;19:323–331.PubMedGoogle Scholar
  195. 195.
    Pear BL. Idiopathic disseminated pulmonary ossification. Radiology 1968;91:746–748.PubMedGoogle Scholar
  196. 196.
    Epstein EJ, Chapman R, Coulshed N, et al. Pulmonary ossific nodule formation in the absence of mitral valve disease: a report of four cases. Am J Heart 1963;65:816–825.Google Scholar
  197. 197.
    Galloway RW, Epstein EJ, Coulshed N. Pulmonary ossific nodules in mitral value disease. Br Heart J 1961;23:297–307.PubMedGoogle Scholar
  198. 198.
    Daugavietis HE, Mautner LS. Disseminated nodular pulmonary ossification with mitral stenosis. AM A Arch Pathol 1957;63:7–12.Google Scholar
  199. 199.
    Elkeles A, Glynn LE. Disseminated parenchymatous ossification in the lungs in association with mitral stenosis. J Pathol Bacteriol 1946;58:517–522.PubMedGoogle Scholar
  200. 200.
    Popelka CG, Kleinerman J. Diffuse pulmonary ossification. Arch Intern Med 1977;137:523–525.PubMedGoogle Scholar
  201. 201.
    Green JD, Harle TS, Greenberg SD, et al. Disseminated pulmonary ossification. A case report with demonstration of electron-microscopic features. Am Rev Respir Dis 1970;101:293–298.PubMedGoogle Scholar
  202. 202.
    Lendrum AC, Scott LDW, Parks SDS. Pulmonary changes due to cardiac diseases, with special reference to hemosiderosis. Q J Med 1950;19:249–262.Google Scholar
  203. 203.
    Katzenstein A-LA, Askin FB. Surgical pathology of nonneoplastic lung disease. Philadelphia: WB Saunders, 1982:371.Google Scholar
  204. 204.
    Kuhn C, III, Kuo TT. Cytoplasmic hyalin in asbestosis. A reaction of injured alveolar epithelium. Arch Pathol 1973;95:190–194.PubMedGoogle Scholar
  205. 205.
    Phillips MJ. Mallory bodies and the liver. Lab Invest 1982;47:311–313.PubMedGoogle Scholar
  206. 206.
    Warnock ML, Press M, Churg A. Further observations on cytoplasmic hyaline in the lung. Hum Pathol 1980;11:59–65.PubMedGoogle Scholar
  207. 207.
    Hammar SP. Personal communication. Seattle, Washington, 1986.Google Scholar
  208. 208.
    Denk H, Franke WW, Eckerstorfer R, et al. Formation and involution of Mallory bodies (“alcoholic hyalin”) in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Natl Acad Sci 1979;76:4112–4116.PubMedGoogle Scholar
  209. 209.
    Michel RP, Limacher JJ, Kimoff RJ. Mallory bodies in scar adenocarcinoma of the lung. Hum Pathol 1982;13:81–85.PubMedGoogle Scholar
  210. 210.
    Dekker A, Krause JR. Hyaline globules in human neoplasms. A report of three autopsy cases. Arch Pathol 1973;95:178–181.PubMedGoogle Scholar
  211. 211.
    Prakash UB, Barham SS, Rosenow EC, III, et al. Pulmonary alveolar microlithiasis. A review including ultrastructural and pulmonary function studies. Mayo Clin Proc 1983;58:290–300.PubMedGoogle Scholar
  212. 212.
    Nolle E, Kaufmann HJ. Pulmonary alveolar microlithiasis in pediatric patients. A review of the world literature and two new observations. Pediatr Radiol 1987;17:439–442.Google Scholar
  213. 213.
    Castellana G, Gentile M, Castellana R, et al. Pulmonary alveolar microlithiasis: clinical features, evolution of the phenotype, and review of the literature. Am J Med Genet 2002;111:220–224.PubMedGoogle Scholar
  214. 214.
    Mariotta S, Ricci A, Papale M, et al. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:173–181.PubMedGoogle Scholar
  215. 215.
    Michaels L, Levene C. Pulmonary corpora amylacea. J Pathol Bacteriol 1957;74:49–56.Google Scholar
  216. 216.
    Harbitz F. Extensive calcification of the lungs as a distinct disease. Arch Intern Med 1918;21:139–146.Google Scholar
  217. 217.
    Puhr L. Mikrolithiasis alveolaris pulmonum. Virchows Arch Pathol Anat 1933;290:156–160.Google Scholar
  218. 218.
    Caffrey PR, Altman RS. Pulmonary alveolar microlithiasis occurring in premature twins. J Pediatr 1965;66:758–763.PubMedGoogle Scholar
  219. 219.
    Thurairajasingam S, Dharmasena BD, Kasthuriratna T. Pulmonary alveolar microlithiasis. Australas Radiol 1975;19:175–180.PubMedGoogle Scholar
  220. 220.
    Thind GS, Bhatia JL. Pulmonary alveolar microlithiasis. Br J Dis Chest 1978;72:151–154.PubMedGoogle Scholar
  221. 221.
    Sosman MC, Dodd GD, Jones WD, et al. The familial occurrence of pulmonary alveolar microlithiasis. Am J Roentgenol Radium Ther Nucl Med 1957;77:947–1012.PubMedGoogle Scholar
  222. 222.
    Castellana G, Lamorgese V. Pulmonary alveolar microlithiasis. World cases and review of the literature. Respiration 2003;70:549–555.PubMedGoogle Scholar
  223. 223.
    Drinkovic I, Strohal K, Sabljica B. Microlithiasis of the pulmonary alveoli. Fortschr Geb Rontgenstr Nuklearmed 1962;97:180–185.PubMedGoogle Scholar
  224. 224.
    Mikhailov V. Klin Med (Mosk) 1954;32:31–36.Google Scholar
  225. 225.
    Jankovic S, Pavlov N, Ivkosic A, et al. Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up. Pediatr Pulmonol 2002;34:384–387.PubMedGoogle Scholar
  226. 226.
    Kino T, Kohara Y, Tsuji S. Pulmonary alveolar microlithiasis. A report of two young sisters. Am Rev Respir Dis 1972;105:105–110.PubMedGoogle Scholar
  227. 227.
    Sears MR, Chang AR, Taylor AJ. Pulmonary alveolar microlithiasis. Thorax 1971;26:704–711.PubMedGoogle Scholar
  228. 228.
    Puleihan FJD, Abboud RT, Balikian JP, et al. Pulmonary alveolar microlithiasis: lung function in five cases. Thorax 1969;24:84–90.Google Scholar
  229. 229.
    Biressi PC, Casassa PM. Intraalveolar pulmonary microlithiasis. Minerva Med 1956;47:930–939.PubMedGoogle Scholar
  230. 230.
    Shigeno C, Fukunaga M, Morita R, et al. Bone scintigraphy in pulmonary alveolar microlithiasis: a comparative study of radioactivity and density distribution. Clin Nucl Med 1982;7:103–107.PubMedGoogle Scholar
  231. 231.
    Brown ML, Swee RG, Olson RJ, et al. Pulmonary uptake of 99mTc diphosphonate in alveolar microlithiasis. AJR 1978;131:703–704.PubMedGoogle Scholar
  232. 232.
    Balkian JP, Fuleihan FJD, Nucho CKN. Pulmonary alveolar microlithiasis: report of 5 cases with special reference to roentgen manifestations. AJR 1968;103:509–518.Google Scholar
  233. 233.
    Pant K, Shah A, Mathur RK, et al. Pulmonary alveolar microlithiasis with pleural calcification and nephrolithiasis. Chest 1990;98:245–246.PubMedGoogle Scholar
  234. 234.
    Petit MA. Pulmonary alveolar microlithiasis. Chest 1991;100:290.PubMedGoogle Scholar
  235. 235.
    Cole WR. Pulmonary alveolar microlithiasis. J Fac Radiol 1959;10:54–56.Google Scholar
  236. 236.
    Winzelberg GG, Boiler M, Sachs M, et al. CT evaluation of pulmonary alveolar microlithiasis. J Comput Assist Tomogr 1984;8:1029–1031.PubMedGoogle Scholar
  237. 237.
    Korn MA, Schurawitzki H, Klepetko W, et al. Pulmonary alveolar microlithiasis: findings on high-resolution CT. AJR 1992;158:981–982.PubMedGoogle Scholar
  238. 238.
    Chalmers AG, Wyatt J, Robinson PJ. Computed tomographic and pathological findings in pulmonary alveolar microlithiasis. Br J Radiol 1986;59:408–411.PubMedGoogle Scholar
  239. 239.
    Tao LC. Microliths in sputum specimens and their relationship to pulmonary alveolar microlithiasis. Am J Clin Pathol 1978;69:482–485.PubMedGoogle Scholar
  240. 240.
    Palombini BC, da Silva PN, Wallau CU, et al. Bronchopulmonary lavage in alveolar microlithiasis. Chest 1981;80:242–243.PubMedGoogle Scholar
  241. 241.
    Sharp ME, Danino EA. An unusual form of pulmonary calcification: microlithiasis alveolaris pulmonum. J Pathol Bacteriol 1953;65:389–399.PubMedGoogle Scholar
  242. 242.
    Kent G, Gilbert ES, Meyer HH. Pulmonary microlithiasis; microlithiasis alveolaris pulmonum. AMA Arch Pathol 1955;60:556–562.PubMedGoogle Scholar
  243. 243.
    Kanat F. Diagnosis of pulmonary alveolar microlithiasis: a comment. Rheumatol Int 2005;25:152–153.PubMedGoogle Scholar
  244. 244.
    Kawakami M, Sato S, Takishima T. Electron microscopic studies on pulmonary alveolar microlithiasis. Tohoku J Exp Med 1978;126:343–361.PubMedGoogle Scholar
  245. 245.
    Bab I, Rosenmann E, Ne’eman Z, et al. The occurrence of extracellular matrix vesicles in pulmonary alveolar microlithiasis. Virchows Arch A Pathol Anat Histol 1981;391:357–361.PubMedGoogle Scholar
  246. 246.
    Greenberg MJ. Miliary shadows in the lungs due to microlithiasis alveolaris pulmonum. Thorax 1957;12:171–174.PubMedGoogle Scholar
  247. 247.
    Nouh MS. Is the desert lung syndrome (nonoccupational dust pneumoconiosis) a variant of pulmonary alveolar microlithiasis? Report of 4 cases with review of the literature. Respiration 1989;55:122–126.PubMedGoogle Scholar
  248. 248.
    Edelman JD, Bavaria J, Kaiser LR, et al. Bilateral sequential lung transplantation for pulmonary alveolar microlithiasis. Chest 1997;112:1140–1144.PubMedGoogle Scholar
  249. 249.
    Friedreich N. Kleinere mittheilungen: I. Corpora amylacea in den lungen. Virchows Arch Pathol Anat 1856;9:613–618.Google Scholar
  250. 250.
    Lubarsch O, Plenge K. Die corpora amylacea. Handb Der Spezielle Pathol Anat U Hist. Vol. 3. Berlin: Springer-Verlag, 1931:607–654.Google Scholar
  251. 251.
    Hollander DH, Hutchins GM. Central spherules in pulmonary corpora amylacea. Arch Pathol Lab Med 1978;102:629–630.PubMedGoogle Scholar
  252. 252.
    Baar HS, Ferguson FF. Microlithiasis alveolaris pulmonum. Association with diffuse interstitial pulmonary fibrosis. Arch Pathol 1963;76:659–666.PubMedGoogle Scholar
  253. 253.
    Steele HD, Kinley G, Leuchtenberger C, et al. Polysaccharide nature of corpora amylacea. AMA Arch Pathol 1952;54:94–97.PubMedGoogle Scholar
  254. 254.
    Dail DH, Liebow AA. Intraalveolar conchoidal bodies. (Abstract). Am J Pathol 1974;76:43A.Google Scholar
  255. 255.
    Michaels L. Lung changes in woodworkers. Can Med Assoc J 1967;96:1150–1155.PubMedGoogle Scholar
  256. 256.
    Gardiner IT, Uff JS. “Blue bodies” in a case of cryptogenic fibrosing alveolitis (desquamative type) an ultra-structural study. Thorax 1978;33:806–813.PubMedGoogle Scholar
  257. 257.
    Koss MN, Johnson FB, Hochholzer L. Pulmonary blue bodies. Hum Pathol 1981;12:258–266.PubMedGoogle Scholar
  258. 258.
    Kim CK, Goyal PC, Payne CB Jr. Pulmonary blue bodies. Hum Pathol 1983;14:739–740.PubMedGoogle Scholar
  259. 259.
    Kung IT, Johnson FB, So SY, et al. Blue bodies in cytology specimens in a case of pulmonary talcosis. Am J Clin Pathol 1984;81:675–678.PubMedGoogle Scholar
  260. 260.
    Williams WJ. The nature and origin of Schaumann bodies. J Pathol Bacteriol 1960;79:193–201.Google Scholar
  261. 261.
    Williams WJ, Williams D. The properties and development of conchoidal bodies in sarcoid and sarcoid-like granulomas. J Pathol Bacteriol 1968;96:491–496.PubMedGoogle Scholar
  262. 262.
    Pritzker KP, Desai SD, Patterson MC, et al. Calcite sputum lith. Characterization by analytic scanning electron microscopy and x-ray diffraction. Am J Clin Pathol 1981;75:253–257.PubMedGoogle Scholar
  263. 263.
    Koss MN, Hochholzer L, Feigin DS, et al. Necrotizing sarcoid-like granulomatosis: clinical, pathologic, and immunopathologic findings. Hum Pathol 1980;11:510–519.PubMedGoogle Scholar
  264. 264.
    Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958;258:1123–1142.PubMedGoogle Scholar
  265. 265.
    Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215–235.PubMedGoogle Scholar
  266. 266.
    Dirksen U, Hattenhorst U, Schneider P, et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood 1998;92:1097–1103.PubMedGoogle Scholar
  267. 267.
    deMello DE, Lin Z. Pulmonary alveolar proteinosis: a review. Pediatr Pathol Mol Med 2001;20:413–432.PubMedGoogle Scholar
  268. 268.
    Presneill JJ, Nakata K, Inoue Y, et al. Pulmonary alveolar proteinosis. Clin Chest Med 2004;25:593–613.PubMedGoogle Scholar
  269. 269.
    Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349:2527–2539.PubMedGoogle Scholar
  270. 270.
    Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005;171:1142–1149.PubMedGoogle Scholar
  271. 271.
    Larson RK, Gordinier R. Pulmonary alveolar proteinosis. Report of six cases, review of the literature, and formulation of a new theory. Ann Intern Med 1965;62:292–212.PubMedGoogle Scholar
  272. 272.
    Prakash UB, Barham SS, Carpenter HA, et al. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 1987;62:499–518.PubMedGoogle Scholar
  273. 273.
    Kariman K, Kylstra JA, Spock A. Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years. Lung 1984;162:223–231.PubMedGoogle Scholar
  274. 274.
    Goldstein LS, Kavuru MS, Curtis-McCarthy P, et al. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest 1998;114:1357–1362.PubMedGoogle Scholar
  275. 275.
    Asamoto H, Kitaichi M, Nishimura K, et al. Primary pulmonary alveolar proteinosis—clinical observation of 68 patients in Japan. Nihon Kyobu Shikkan Gakkai Zasshi 1995;33:835–845.PubMedGoogle Scholar
  276. 276.
    Rubinstein I, Mullen JB, Hoffstein V. Morphologic diagnosis of idiopathic pulmonary alveolar lipoproteinosis-revisited. Arch Intern Med 1988;148:813–816.PubMedGoogle Scholar
  277. 277.
    Ben Dov I, Kishinevski Y, Roznman J, et al. Pulmonary alveolar proteinosis in Israel: ethnic clustering. Isr Med Assoc J 1999;1:75–78.PubMedGoogle Scholar
  278. 278.
    Mazzone P, Thomassen MJ, Kavuru MS. Pulmonary alveolar proteinosis: recent advances. Semin Respir Crit Care Med 2002;23:115–126.PubMedGoogle Scholar
  279. 279.
    Gough J. Silicosis and alveolar proteinosis. Br Med J 1967;1:629.PubMedGoogle Scholar
  280. 280.
    Buechner HA, Ansari A. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969;55:274–278.PubMedGoogle Scholar
  281. 281.
    Hoffman EO, Lamberty J, Pizzolato P. The ultrastructure of acute silicosis. Arch Pathol Lab Med 1973;96:104–107.Google Scholar
  282. 282.
    Xipell JM, Ham KN, Price CG, et al. Acute silicoproteinosis. Thorax 1977;32:104–111.PubMedGoogle Scholar
  283. 283.
    Suratt PM, Winn WC Jr, Brody AR, et al. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 1977;115:521–529.PubMedGoogle Scholar
  284. 284.
    Miller RR, Churg AM, Hutcheon M, et al. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984;130:312–315.PubMedGoogle Scholar
  285. 285.
    Abraham JL, Auchinclos JH. Pulmonary alveolar proteinosis and kaolin exposure. Am Rev Respir Dis 1985;131:A203 (abstr).Google Scholar
  286. 286.
    Gross P, DeTreville RT. Alveolar proteinosis. Its experimental production in rodents. Arch Pathol 1968;86:255–261.PubMedGoogle Scholar
  287. 287.
    Corrin B, King E. Experimental endogenous lipid pneumonia and silicosis. J Pathol 1969;97:325–330.PubMedGoogle Scholar
  288. 288.
    Heppleston AG, Wright NA, Stewart JA. Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol 1970;101:293–307.PubMedGoogle Scholar
  289. 289.
    Heppleston AG, Young AE. Alveolar lipo-proteinosis: an ultrastructural comparison of the experimental and human forms. J Pathol 1972;107:107–117.PubMedGoogle Scholar
  290. 290.
    Martin TR, Wehner AP, Butler J. Pulmonary toxicity of Mt. St. Helens volcanic ash. A review of experimental studies. Am Rev Respir Dis 1983;128:158–162.PubMedGoogle Scholar
  291. 291.
    Corrin B, King E. Pathogenesis of experimental pulmonary alveolar proteinosis. Thorax 1970;25:230–236.PubMedGoogle Scholar
  292. 292.
    Gross P, Harley RA Jr, DeTreville RT. Pulmonary reaction to metallic aluminum powders: an experimental study. Arch Environ Health 1973;26:227–236.PubMedGoogle Scholar
  293. 293.
    Schober R, Kosek JC, Bensch KG. Origin of the membranous intraalveolar material in pulmonary alveolar proteinosis. Lab Invest 1974;30:388–389.Google Scholar
  294. 294.
    Likhaechev I, Batsura I, Direev VI. The role of several occupational factors in the development of pulmonary alveolar proteinosis (an experimental study). Arkh Patol 1975;37:63–69.PubMedGoogle Scholar
  295. 295.
    Lakshminarayan S, Schwarz MI, Stanford RE. Unsuspected pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Chest 1976;69:433–435.PubMedGoogle Scholar
  296. 296.
    Bedrossian CW, Luna MA, Conklin RH, et al. Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations. Hum Pathol 1980;11:527–535.PubMedGoogle Scholar
  297. 297.
    Doyle AP, Balcerzak SP, Wells CL, et al. Pulmonary alveolar proteinosis with hematologic disorders. Arch Intern Med 1963;112:940–946.PubMedGoogle Scholar
  298. 298.
    Steer A. Focal pulmonary alveolar proteinosis in pulmonary tuberculosis. Arch Pathol 1969;87:347–352.PubMedGoogle Scholar
  299. 299.
    Payseur CR, Konwaler BE, Hyde L. Pulmonary alveolar proteinosis; a progressive, diffuse, fatal pulmonary disease. Am Rev Tuberc 1958;78:906–915.PubMedGoogle Scholar
  300. 300.
    Reyes JM, Putong PB. Association of pulmonary alveolar lipoproteinosis with mycobacterial infection. Am J Clin Pathol 1980;74:478–485.PubMedGoogle Scholar
  301. 301.
    Pascual J, Gomez Aguinaga MA, Vidal R, et al. Alveolar proteinosis and nocardiosis: a patient treated by bronchopulmonary lavage. Postgrad Med J 1989;65:674–677.PubMedGoogle Scholar
  302. 302.
    Ruben FL, Talamo TS. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med 1986;80:1187–1190.PubMedGoogle Scholar
  303. 303.
    Butnor KJ, Sporn TA. Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis. Arch Pathol Lab Med 2003;127:235–238.PubMedGoogle Scholar
  304. 304.
    Tran VN, Vojtek AM, Bernaudin JF, et al. Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients. Chest 1990;98:801–805.Google Scholar
  305. 305.
    Gal AA, Bryan JA, Kanter KR, et al. Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation. J Heart Lung Transplant 2004;23:135–138.PubMedGoogle Scholar
  306. 306.
    Yousem SA. Alveolar lipoproteinosis in lung allograft recipients. Hum Pathol 1997;28:1383–1386.PubMedGoogle Scholar
  307. 307.
    Johkoh T, Itoh H, Muller NL, et al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology 1999;211:155–160.PubMedGoogle Scholar
  308. 308.
    Maygarden SJ, Iacocca MV, Funkhouser WK, et al. Pulmonary alveolar proteinosis: a spectrum of cytologic, histochemical, and ultrastructural findings in bronchoalveolar lavage fluid. Diagn Cytopathol 2001;24:389–395.PubMedGoogle Scholar
  309. 309.
    Corsello BF, Choi H. Basophilic staining in pulmonary alveolar proteinosis. Report of three cases. Arch Pathol Lab Med 1984;108:68–70.PubMedGoogle Scholar
  310. 310.
    Singh G, Katyal SL, Bedrossian CW, et al. Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983;83:82–86.PubMedGoogle Scholar
  311. 311.
    Colon AR Jr, Lawrence RD, Mills SD, et al. Childhood pulmonary alveolar proteinosis (PAP). Report of a case and review of the literature. Am J Dis Child 1971;121:481–485.PubMedGoogle Scholar
  312. 312.
    William GE. Pulmonary alveolar proteinosis. Lancet 1960;1385-1388.Google Scholar
  313. 313.
    Sieracki JC, Horn RC Jr, Kay S. Pulmonary alveolar proteinosis: report of three cases. Ann Intern Med 1959;51:728–739.PubMedGoogle Scholar
  314. 314.
    Singh G, Katyal SL. Surfactant apoprotein in nonmalignant pulmonary disorders. Am J Pathol 1980;101:51–62.PubMedGoogle Scholar
  315. 315.
    Bjorkholm B, Elgefors B. Cerebellar aspergilloma. Scand J Infect Dis 1986;18:375–378.PubMedGoogle Scholar
  316. 316.
    Fried J, Hinthorn D, Ralstin J, et al. Cure of brain abscess caused by Nocardia asteroides resistant to multiple antibiotics. South Med J 1988;81:412–413.PubMedGoogle Scholar
  317. 317.
    Abdul Rahman JA, Moodley YP, Phillips MJ. Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage. Respirology 2004;9:419–422.PubMedGoogle Scholar
  318. 318.
    Goldschmidt N, Nusair S, Gural A, et al. Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Am J Hematol 2003;74:221–223.PubMedGoogle Scholar
  319. 319.
    Burbank B, Morrione TG, Cutler SS. Pulmonary alveolar proteinosis and nocardiosis. Am J Med 1960;28:1002–1007.PubMedGoogle Scholar
  320. 320.
    Carlsen ET, Hill RB Jr, Rowlands DT Jr. Nocardiosis and pulmonary alveolar proteinosis. Ann Intern Med 1964;60:275–281.PubMedGoogle Scholar
  321. 321.
    Ramirez J, Savard EV, Hawkins JE. Biological effect of pulmonary washings from cases of alveolar proteinosis. Am Rev Respir Dis 1966;94:244–246.PubMedGoogle Scholar
  322. 322.
    Golde DW, Territo M, Finley TN, et al. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976;85:304–309.PubMedGoogle Scholar
  323. 323.
    Harris JO. Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages. Chest 1979;76:156–159.PubMedGoogle Scholar
  324. 324.
    Kuhn C, Gyorkey F, Levine BE, et al. Pulmonary alveolar proteinosis. A study using enzyme histochemistry, electron microscopy, and surface tension measurement. Lab Invest 1966;15:492–509.PubMedGoogle Scholar
  325. 325.
    Basset F, Soler P, Turiaf J. Etude ultrastructurale du contenu alveolar dans la protéinose alvéolaire pulmonaire et dans les pseudoprotéinoses. Am Med Interne (Paris) 1973;24:279–290.Google Scholar
  326. 326.
    Costello JF, Moriarty DC, Branthwaite MA, et al. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975;30:121–132.PubMedGoogle Scholar
  327. 327.
    Ramirez J, Harlan WR Jr. Pulmonary alveolar proteinosis, nature and origin of alveolar lipid. Am J Med 1968;45:502–512.PubMedGoogle Scholar
  328. 328.
    McClenahan JB. Pulmonary alveolar proteinosis. Arch Intern Med 1974;133:284–287.PubMedGoogle Scholar
  329. 329.
    Alberti A, Luisetti M, Braschi A, et al. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med 1996;154:817–820.PubMedGoogle Scholar
  330. 330.
    Doyle IR, Davidson KG, Barr HA, et al. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med 1998;157:658–664.PubMedGoogle Scholar
  331. 331.
    Honda Y, Takahashi H, Shijubo N, et al. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993;103:496–499.PubMedGoogle Scholar
  332. 332.
    Crouch E, Persson A, Chang D. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 1993;142:241–248.PubMedGoogle Scholar
  333. 333.
    Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860–1866.PubMedGoogle Scholar
  334. 334.
    Brasch F, Birzele J, Ochs M, et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 2004;24:426–435.PubMedGoogle Scholar
  335. 335.
    Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002;347:2141–2148.PubMedGoogle Scholar
  336. 336.
    Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002;64:775–802.PubMedGoogle Scholar
  337. 337.
    Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci 1994;91:5592–5596.PubMedGoogle Scholar
  338. 338.
    Thomassen MJ, Yi T, Raychaudhuri B, et al. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol 2000;95:85–92.PubMedGoogle Scholar
  339. 339.
    Bonfield TL, Russell D, Burgess S, et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002;27:481–486.PubMedGoogle Scholar
  340. 340.
    Uchida K, Nakata K, Trapnell BC, et al. High-affinity auto-antibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004;103:1089–1098.PubMedGoogle Scholar
  341. 341.
    Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190:875–880.PubMedGoogle Scholar
  342. 342.
    Ramirez J. Bronchopulmonary lavage. New techniques and observations. Dis Chest 1966;50:581–588.PubMedGoogle Scholar
  343. 343.
    Ramirez J. Alveolar proteinosis: importance of pulmonary lavage. Am Rev Respir Dis 1971;103:666–678.PubMedGoogle Scholar
  344. 344.
    Cordonnier C, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149:788–794.PubMedGoogle Scholar
  345. 345.
    Kavuru MS, Sullivan EJ, Piccin R, et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161:1143–1148.PubMedGoogle Scholar
  346. 346.
    Knight DP, Knight JA. Pulmonary alveolar proteinosis in the newborn. Arch Pathol Lab Med 1985;109:529–531.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Carol F. Farver
    • 1
  • David H. Dail
    • 2
  1. 1.Pulmonary Pathology, Department of Anatomic PathologyThe Cleveland Clinic FoundationClevelandUSA
  2. 2.Department of PathologyVirginia Mason Medical CenterSeattleUSA

Personalised recommendations